162 related articles for article (PubMed ID: 31627177)
1. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial.
Wang XS; Shi Q; Mendoza T; Lin S; Chang JY; Bokhari RH; Lin HK; Garcia-Gonzalez A; Kamal M; Cleeland CS; Liao Z
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):100-107. PubMed ID: 31627177
[TBL] [Abstract][Full Text] [Related]
2. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial.
Wang XS; Shi Q; Bhadkamkar NA; Cleeland CS; Garcia-Gonzalez A; Aguilar JR; Heijnen C; Eng C
J Pain Symptom Manage; 2019 Oct; 58(4):662-671. PubMed ID: 31254639
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.
Kamal M; Wang XS; Shi Q; Mendoza T; Garcia-Gonzalez A; Bokhari RH; Cleeland CS; Fogelman DR
J Pain Symptom Manage; 2020 May; 59(5):1052-1058.e1. PubMed ID: 31982605
[TBL] [Abstract][Full Text] [Related]
5. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial.
Wang XS; Shi Q; Mendoza TR; Garcia-Gonzalez A; Chen TY; Kamal M; Chen TH; Heijnen C; Orlowski RZ; Cleeland CS
Support Care Cancer; 2021 Oct; 29(10):6099-6107. PubMed ID: 33792800
[TBL] [Abstract][Full Text] [Related]
6. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.
Sio TT; Atherton PJ; Pederson LD; Zhen WK; Mutter RW; Garces YI; Ma DJ; Leenstra JL; Rwigema JM; Dakhil S; Bearden JD; van der Veen SJ; Ganti AK; Schild SE; Miller RC
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):686-696. PubMed ID: 30395904
[TBL] [Abstract][Full Text] [Related]
7. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial.
Gunn GB; Mendoza TR; Garden AS; Wang XS; Shi Q; Morrison WH; Frank SJ; Phan J; Fuller CD; Chambers MS; Hanna EY; Lu C; Rosenthal DI; Cleeland CS
Support Care Cancer; 2020 Jan; 28(1):261-269. PubMed ID: 31037378
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.
Wang XS; Shi Q; Williams LA; Mao L; Cleeland CS; Komaki RR; Mobley GM; Liao Z
Brain Behav Immun; 2010 Aug; 24(6):968-74. PubMed ID: 20353817
[TBL] [Abstract][Full Text] [Related]
9. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
[TBL] [Abstract][Full Text] [Related]
11. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study.
Kariya M; Yamamoto K; Kawamura A; Tanizaki S; Ueda K; Sai K; Hata A
Support Care Cancer; 2024 Jun; 32(6):400. PubMed ID: 38829486
[TBL] [Abstract][Full Text] [Related]
12. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.
Edelman MJ; Hu C; Le QT; Donington JS; D'Souza WD; Dicker AP; Loo BW; Gore EM; Videtic GMM; Evans NR; Leach JW; Diehn M; Feigenberg SJ; Chen Y; Paulus R; Bradley JD
J Thorac Oncol; 2017 Sep; 12(9):1413-1420. PubMed ID: 28629896
[TBL] [Abstract][Full Text] [Related]
13. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
15. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts C; Socinski MA; Mitchell PL; Thatcher N; Havel L; Krzakowski M; Nawrocki S; Ciuleanu TE; Bosquée L; Trigo JM; Spira A; Tremblay L; Nyman J; Ramlau R; Wickart-Johansson G; Ellis P; Gladkov O; Pereira JR; Eberhardt WE; Helwig C; Schröder A; Shepherd FA;
Lancet Oncol; 2014 Jan; 15(1):59-68. PubMed ID: 24331154
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
[TBL] [Abstract][Full Text] [Related]
17. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
Wang J; Pang QS; Wang P; Wang J; Wang W
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
19. Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial.
Hoover DA; Capaldi DP; Sheikh K; Palma DA; Rodrigues GB; Dar AR; Yu E; Dingle B; Landis M; Kocha W; Sanatani M; Vincent M; Younus J; Kuruvilla S; Gaede S; Parraga G; Yaremko BP
BMC Cancer; 2014 Dec; 14():934. PubMed ID: 25496482
[TBL] [Abstract][Full Text] [Related]
20. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L
JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
